Controversies in the management of febrile neutropenic cancer patients.

Suppr

超能文献

作者信息

Rubin M, Hathorn J W, Pizzo P A

机构信息

Infectious Disease Section, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Cancer Invest. 1988;6(2):167-84. doi: 10.3109/07357908809077045.

DOI:10.3109/07357908809077045

PMID:3132310

Abstract

摘要

相似文献

Controversies in the management of febrile neutropenic cancer patients.

Cancer Invest. 1988;6(2):167-84. doi: 10.3109/07357908809077045.

Management of fever in granulocytopenic children with cancer.

Pediatr Infect Dis J. 1993 Apr;12(4):330-7. doi: 10.1097/00006454-199304000-00013.

Management of fever in neutropenic patients.

J Infect Chemother. 2001 Mar;7(1):1-9. doi: 10.1007/s101560170027.

Neutropenia and fever.

Pediatr Infect Dis. 1983 May-Jun;2(3 Suppl):S14-7.

Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.

J Hosp Infect. 1990 Apr;15 Suppl A:41-8. doi: 10.1016/0195-6701(90)90078-3.

Drug therapy management of the febrile neutropenic cancer patient.

Cancer Pract. 1993 Nov-Dec;1(4):295-304.

Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.

NCI Monogr. 1990(9):117-22.

Management of infections in immunocompromised cancer patients.

Haematologica. 1984 Sep-Oct;69(5):576-97.

Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.

Pediatr Infect Dis J. 1988 Mar;7(3):165-70. doi: 10.1097/00006454-198803000-00006.

Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).

Eur J Cancer Clin Oncol. 1981 Dec;17(12):1315-22. doi: 10.1016/0014-2964(81)90014-1.

引用本文的文献

Successful Management of Pediatric Patients with Low-Risk Febrile Neutropenia Using a Clinical Care Pathway in Egypt.

Infect Chemother. 2025 Jun;57(2):288-295. doi: 10.3947/ic.2025.0009. Epub 2025 Apr 16.

Multicentre Canadian clinical trials on neutropenic patients.

Can J Infect Dis. 1992 Mar;3(2):78-81. doi: 10.1155/1992/518509.

Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.

Support Care Cancer. 2008 Feb;16(2):181-91. doi: 10.1007/s00520-007-0308-x. Epub 2007 Oct 18.

Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.

Support Care Cancer. 2008 May;16(5):485-91. doi: 10.1007/s00520-007-0334-8. Epub 2007 Sep 25.

Management of febrile neutropenia in the United Kingdom: time for a national trial?

Br J Cancer. 2005 Dec 12;93(12):1324-8. doi: 10.1038/sj.bjc.6602872.

The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.

Paediatr Drugs. 2003;5(10):673-84. doi: 10.2165/00148581-200305100-00003.

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.

Br J Cancer. 2003 Jul 7;89(1):43-9. doi: 10.1038/sj.bjc.6600993.

Outpatient therapy for febrile neutropenia: clinical and economic implications.

Pharmacoeconomics. 2003;21(6):397-413. doi: 10.2165/00019053-200321060-00004.

Risk assessment and risk-based therapy in febrile neutropenic patients.

Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):461-3. doi: 10.1007/BF01691127.

Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.

Support Care Cancer. 1996 Sep;4(5):358-63. doi: 10.1007/BF01788842.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验